High-sensitivity time-resolved fluorescence immunoassay early warning system and control method
The high-sensitivity time-degrading fluorescent immunoassay system addresses the limitations of traditional virus detection and tracking methods by using a triple test reagent card and AI algorithms for rapid, accurate detection and risk assessment of multiple viruses, enhancing public health response efficiency.
Patent Information
- Application Number
- CN202411305291.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Traditional virus detection methods, such as PCR, are time-consuming and require laboratory environments, while manual epidemiological tracking is prone to information lag and omission, making it difficult to accurately and efficiently identify and track potential infected individuals, especially in situations involving multiple viruses and complex itineraries.
A high-sensitivity time-degrading fluorescent immunoassay system that uses a triple test reagent card to simultaneously detect novel coronavirus, monkeypox virus, and influenza A virus antigens, combined with modules for identity, itinerary, and route information acquisition, and an analysis and warning module for real-time risk assessment using AI algorithms.
The system provides rapid, accurate detection and real-time risk assessment, reducing manual intervention and operational complexity, enabling timely and effective public health responses to potential epidemics by integrating multi-dimensional data analysis.
Smart Images

Figure CN119092146A_ABST
Abstract
Description
Technical Field
[0001] The present specification relates to the field of public health, and more specifically, the present application relates to a high-sensitivity time-degrading fluorescent immunoassay early warning system and control method. Background Art
[0002] In the current public health field, especially in the prevention and control of infectious diseases, accurate and rapid identification and tracking of potential infected persons is key. However, traditional virus detection methods usually rely on PCR (polymerase chain reaction) technology, which has high sensitivity but takes a long time to get results and has high requirements for laboratory environment. In addition, traditional epidemiological tracking methods mainly rely on manual recording and analysis of the travel and contact history of the tested persons, which is prone to information lag or omission, thus affecting the timeliness and effectiveness of prevention and control work.
[0003] At the same time, with the simultaneous spread of multiple viruses, such as the new coronavirus, monkeypox virus, and influenza A virus, higher requirements are placed on the detection system. Single pathogen detection can no longer meet the complex situation of multiple viruses coexisting. In addition, with the frequent flow of people, risk assessment based on itineraries and routes of action has become more important, but the existing technology has limited integration and real-time analysis capabilities in this regard, making it difficult to warn of potential risks on an efficient and accurate basis. Summary of the invention
[0004] A series of simplified concepts are introduced in the Summary of the Invention section, which will be further described in detail in the Detailed Description of the Invention section. The Summary of the Invention section of this application does not mean to attempt to define the key features and essential technical features of the claimed technical solution, nor does it mean to attempt to determine the scope of protection of the claimed technical solution.
[0005] In the first aspect, the present application proposes a high-sensitivity time-degrading fluorescent immunoassay early warning system, comprising: The module for obtaining the identity of the person under test is used to obtain the identity information of the person under test; A module for acquiring virus test results of a tested person, which is used to obtain the virus test results of the tested person, wherein the virus test results are determined based on the image information of the triple test reagent card, which is used to detect novel coronavirus, monkeypox virus and influenza A virus antigens, and the triple test reagent card is based on time-delayed fluorescence immunoassay to determine the virus test results; A module for acquiring the itinerary information of the person under test, used to acquire the itinerary information of the transportation vehicle taken by the person under test based on the identity information of the person; A module for acquiring the movement route of the person under test, which is used to acquire the movement route information of the person under test in the waiting place corresponding to the transportation means after the person under test takes the transportation means based on the identity information of the person under test; The analysis and warning module is used to generate warning information based on the above virus detection results, travel information and the above action route information.
[0006] In a second aspect, the present application proposes a control method for the high-sensitivity time-degradation fluorescence immunoassay early warning system described in the first aspect, comprising: Control the above-mentioned measured person identity acquisition module to obtain the identity information of the measured person; Control the above-mentioned test person virus detection result acquisition module to obtain the test person's virus detection result, wherein the above-mentioned virus detection result is determined based on the image information of the triple test reagent card, and the above-mentioned triple test reagent card is used to detect the new coronavirus, monkeypox virus and influenza A virus antigen; Control the above-mentioned measured person's travel information acquisition module to obtain the travel information of the measured person's corresponding means of transportation based on the above-mentioned person's identity information; Control the above-mentioned measured person's action route acquisition module to obtain the measured person's action route information in the waiting place corresponding to the above-mentioned transportation tool after taking the transportation tool based on the above-mentioned person's identity information; Control the above-mentioned analysis and warning module to form warning information according to the above-mentioned virus detection results, travel information and the above-mentioned action route information.
[0007] In a feasible implementation, the triple test reagent card comprises a test strip, a diluent and a card housing; The test strip comprises a strip-shaped PVC bottom plate, on which a sample pad, a marker binding pad, a nitrocellulose membrane and absorbent paper are arranged in sequence from the first end to the second end, the sample pad is superimposed on the marker binding pad, and the nitrocellulose membrane is equidistantly arranged with a T1 reaction zone, a T2 reaction zone, a T3 reaction zone and a C reference zone from the first end to the second end; The T1 reaction area is coated with the novel coronavirus N protein mAb, the T2 reaction area is coated with the monkeypox virus A29L protein mAb, the T3 reaction area is coated with the influenza A virus NP protein mAb, and the C reference area is coated with goat anti-chicken IgY; The marker binding pad is sprayed with a mixture of novel coronavirus N protein mAb, monkeypox virus A29L protein mAb, influenza A virus NP protein mAb and chicken IgY labeled with lanthanide europium fluorescent microspheres; The card housing is composed of an upper housing and a lower housing. The upper housing is provided with a sample loading hole and a window hole which penetrate longitudinally. The sample loading hole is located directly above the sample pad. The window hole is located directly above the nitrocellulose membrane. On one side of the window hole, there are corresponding regional markings of the T1 reaction area, the T2 reaction area, the T3 reaction area and the C reference area. The test strip is placed on the lower card housing, and the upper housing is tightly buckled with the lower housing.
[0008] In a feasible implementation, the specific preparation and testing steps of the triple test reagent card include: Use lanthanide europium fluorescent microspheres to label the monoclonal antibodies of the SARS-CoV-2 N protein, monkeypox virus A29L protein, influenza A virus NP protein, and chicken IgY to make fluorescent detection probes; The fluorescent detection probes are diluted respectively, sprayed on the corresponding positions of the nitrocellulose membrane, and dried for storage; Soak the sample pad in the treatment solution and dry it, and cut the absorbent paper into preset sizes for later use; The marker binding pad, sample pad, nitrocellulose membrane and absorbent paper assembly are pasted on a PVC plate, cut into reagent strips and loaded into a card housing to prepare the above triple test reagent card.
[0009] In a feasible implementation manner, the above-mentioned control module for obtaining the virus detection result of the tested person obtains the virus detection result of the tested person, including: Based on the above-mentioned test person virus detection result acquisition module, the image information of the triple test reagent card of the above-mentioned test person is obtained; Obtaining a grayscale histogram of the image information of the triple test reagent card; Determine the image entropy value based on the grayscale histogram; When the image entropy value is greater than a preset threshold, the image information of the triple test reagent card is input into a first identifier to obtain a first virus detection result, wherein the first identifier is established based on a support vector machine; When the image entropy value is greater than or equal to the preset threshold, the image information of the triple test reagent card is input into a second identifier to obtain a second virus detection result, wherein the second identifier is established based on a deep residual network and a random forest algorithm; The first virus detection result or the second virus detection result is used as the virus detection result of the tested person.
[0010] In a feasible implementation manner, the module for controlling the movement route acquisition of the measured person acquires the movement route information of the measured person in the waiting place corresponding to the transportation means after the measured person takes the transportation means based on the identity information of the measured person, including: Control the above-mentioned measured person's action route acquisition module to acquire entrance image information at the entrance of the waiting place; Matching the above-mentioned entrance image information with the identity information of the person being tested based on the first timestamp information to obtain entrance matching information; Control the above-mentioned measured person's action route acquisition module to acquire exit image information at the exit of the waiting place; Matching the exit image information with the identity information of the person being tested based on the second timestamp information to obtain exit matching information; Obtaining camera image information at different positions between the first timestamp information and the second timestamp information; According to all the camera graphic information, the above-mentioned entrance matching information and the above-mentioned exit matching information, matching is performed based on the FasterR-CNN algorithm and the Hungarian algorithm to obtain the action route information in the waiting area.
[0011] In a feasible implementation manner, the control of the analysis and warning module generates warning information according to the virus detection result, the travel information and the action route information, including: The control analysis and early warning module determines the risk score R based on the following formula: ; α, β, and γ are weight coefficients used to adjust the influence of various factors on the final risk score R. V represents the risk score of the virus test result, T represents the risk score of the itinerary information, and M represents the risk score of the action route information. The above-mentioned warning information is determined based on the above-mentioned risk score R and threshold information.
[0012] In a feasible implementation, the risk score V of the above virus detection result is determined based on the following formula: ; N represents the number of virus types detected; N max is the maximum reference value of the number of virus species; R 0 is the basic reproduction number, which means the average number of people that an infected person can infect in the absence of intervention measures and a generally susceptible population; S is the coefficient of the impact of seasonal factors on virus transmission, reflecting the activity and transmission ability of the virus in different seasons; A is the coefficient of the virus transmission risk in the target area; P is the coefficient of the impact of population density in the area where the tested person is located on virus transmission; E is the coefficient of the intensity of epidemic prevention measures taken in the area or place; H is the coefficient of the health status of the tested person himself.
[0013] In a feasible implementation manner, the specific steps of determining the risk score of the above-mentioned travel information include: Get historical travel information for a preset period; Extracting risk area arrival information, travel frequency information and transportation type information based on the above historical travel information; A weighted sum is performed based on the risk area arrival information, the travel frequency information and the transportation type information to obtain a risk score for the trip information.
[0014] In a feasible implementation manner, the specific steps of determining the risk score of the above-mentioned action route information include: Based on the action route information in the above waiting place, the time series analysis method is used to obtain the scores of the length of stay of the measured persons in different places; Based on the action route information in the above waiting place, the contact number score of the tested person is obtained by the Faster R-CNN method; Based on the action route information in the above waiting place, geospatial analysis is used in combination with the DBSCAN method to obtain the high-risk area score of the tested person; The risk score of the above-mentioned action route information is determined based on the length of stay scores at the above-mentioned different locations, the above-mentioned number of contacts scores and the above-mentioned high-risk area scores.
[0015] In summary, compared with the related art, the high-sensitivity time-solution fluorescent immunoassay early warning system of the present application, using a triple test reagent card combined with a time-solution fluorescent immunoassay, can simultaneously detect novel coronavirus, monkeypox virus and influenza A virus antigens. Compared with traditional single pathogen detection, this method identifies multiple viruses in the same detection process, greatly improving detection efficiency and accuracy. The time-solution fluorescent immunoassay has extremely high sensitivity and specificity, and can accurately detect low concentrations of viral antigens in the early stage, which helps to detect potential infected persons early. The system obtains the identity information, itinerary information and route information of the tested person, and integrates and analyzes this information with the virus detection results. Compared with the traditional decentralized data processing method, the present application scheme can realize real-time synchronization and comprehensive analysis of data in one system, thereby quickly identifying high-risk personnel and providing accurate warnings. The itinerary information acquisition module and the route acquisition module process complex geographic and behavioral data through intelligent algorithms, and analyze and evaluate the potential exposure risks of the tested person in real time. This comprehensive analysis capability based on big data and artificial intelligence is significantly better than traditional manual tracking and simple data comparison methods. The analysis and early warning module can more comprehensively reflect the real risk level of the tested person from the comprehensive evaluation of multidimensional data based on the virus detection results, avoiding the early warning lag caused by incomplete data or untimely processing. The high sensitivity and multi-dimensional analysis capabilities of the system ensure the accuracy and timeliness of the early warning, which helps public health management departments to respond quickly and effectively to potential epidemic threats and minimize the risk of disease transmission. Through automated data collection, analysis and early warning, this application scheme greatly reduces the need for manual intervention, reduces operational complexity and error rate. Compared with traditional methods, the system can significantly improve the efficiency of public health prevention and control, and help relevant departments make faster and more accurate decisions in epidemic prevention and control. In addition, the system design also takes into account scalability and adaptability, and can be adjusted and optimized according to different application scenarios and virus types to meet different prevention and control needs. This application integrates high-sensitivity time-decomposition fluorescence immunoassay technology, multi-dimensional data collection and intelligent analysis methods to achieve efficient detection and accurate early warning of new coronavirus, monkeypox virus and influenza A virus. It not only improves the accuracy and efficiency of detection and risk assessment, but also provides a more comprehensive and intelligent solution for epidemic prevention and control, which has important application value in the field of public health.
[0016] The high-sensitivity time-degrading fluorescent immunoassay early warning system and control method proposed in this application, and other advantages, objectives and features of this application will be partially reflected in the following description, and will also be partially understood by technical personnel in this field through research and practice of this application. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present specification. Also, the same reference symbols are used throughout the accompanying drawings to represent the same components. In the accompanying drawings: Figure 1 A structural schematic diagram of a high-sensitivity time-degrading fluorescent immunoassay early warning system provided in an embodiment of the present application; Figure 2 A schematic diagram of the process of controlling the high-sensitivity time-degradation fluorescence immunoassay early warning system provided in an embodiment of the present application; Figure 3 A schematic diagram of the structure of a triple test reagent card provided in an embodiment of the present application; Figure 4 A schematic structural diagram of a triple test reagent strip in a triple test reagent card provided in an embodiment of the present application; Figure 3 and 4 The corresponding relationship between the reference numerals and component names is as follows: 1: card, 2: test strip, 3: T1 line (new coronavirus), 4: T2 line (monkeypox virus), 5: T3 line (influenza A virus), 6: C line, 7: loading hole, 8: sample pad, 9: marker pad, 10: absorbent pad. DETAILED DESCRIPTION
[0018] The terms "first", "second", "third", "fourth", etc. (if any) in the specification and claims of this application and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchangeable where appropriate, so that the embodiments described herein can be implemented in an order other than that illustrated or described herein. In addition, the terms "including" and "having" and any of their variations are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices. The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments.
[0019] See also Figure 1 , is a structural schematic diagram of a high-sensitivity time-degrading fluorescent immunoassay early warning system 100 provided in an embodiment of the present application, which may specifically include: The module 101 for obtaining the identity of the person under test is used to obtain the identity information of the person under test; The module 102 for obtaining the virus test result of the tested person is used to obtain the virus test result of the tested person, wherein the virus test result is determined based on the image information of the triple test reagent card, wherein the triple test reagent card is used to detect the novel coronavirus, monkeypox virus and influenza A virus antigens, and wherein the triple test reagent card is used to determine the virus test result based on the time-delayed fluorescence immunoassay method; The measured person's travel information acquisition module 103 is used to acquire the travel information of the measured person's corresponding transportation vehicle based on the above-mentioned person's identity information; The measured person's action route acquisition module 104 is used to obtain the measured person's action route information in the waiting place corresponding to the transportation means after taking the transportation means based on the identity information of the above-mentioned person; The analysis and warning module 105 is used to generate warning information based on the above virus detection results, travel information and the above action route information.
[0020] Exemplarily, the function of the tested person identity acquisition module 101 is to obtain the identity information of the tested person. Such identity information may include a personal ID number, passport number or other identity data that can uniquely identify the person. When the tested person enters the testing process, the system first obtains his / her identity information through the tested person identity acquisition module 101. This information will be used in association in the subsequent acquisition and analysis of virus test results, travel information and route information to ensure that all data accurately corresponds to the correct individual.
[0021] The test person virus test result acquisition module 102 is used to obtain the virus test result of the test person. The test result is determined based on the image information of the triple test reagent card. The triple test reagent card is used to detect the new coronavirus, monkeypox virus and influenza A virus antigens. The reagent card determines the virus test result by time-degradation fluorescence immunoassay. After the sample of the test person reacts with the triple test reagent card, the system reads the fluorescent signal on the card through image recognition technology to obtain the virus test result.
[0022] The measured person's travel information acquisition module 103 acquires the travel information of the corresponding means of transportation based on the measured person's identity information. After acquiring the identity information, the system searches and extracts the travel data associated with the person through the measured person's travel information acquisition module 103. The data includes detailed information such as the type of transportation (such as airplane, train, etc.), departure place, destination, departure time, and arrival time. This information helps analyze the movement trajectory of the person and the potential exposure risk.
[0023] The measured person's action route acquisition module 104 is used to obtain the measured person's action route information in the waiting area corresponding to the above-mentioned transportation after taking the transportation. Through the measured person's action route acquisition module 104, the system can track the measured person's activity path in the waiting area. Combined with identity information, the system can use cameras, positioning systems and other means to record the measured person's action route, such as the length of stay in the waiting area, the places passed, and the contact with other people. These data are used to further analyze their potential exposure risks.
[0024] The analysis and warning module 105 generates warning information based on the virus test results, travel information and route information of the tested person. The analysis and warning module 105 collects and integrates all the above information and uses a specific algorithm to calculate the comprehensive risk score of the tested person. If the score exceeds the preset threshold, the system will generate a warning message. The warning message may indicate potential health risks, such as infection with the new coronavirus, monkeypox virus or influenza A virus, and recommend further protective measures.
[0025] In summary, compared with the relevant technical techniques, the high-sensitivity time-solution fluorescent immunoassay early warning system of the present application, using a triple test reagent card combined with a time-solution fluorescent immunoassay, can simultaneously detect novel coronavirus, monkeypox virus and influenza A virus antigens. Compared with traditional single pathogen detection, this method identifies multiple viruses in the same detection process, greatly improving detection efficiency and accuracy. The time-solution fluorescent immunoassay has extremely high sensitivity and specificity, and can accurately detect low concentrations of viral antigens in the early stage, which helps to detect potential infected persons at an early stage. The system obtains the identity information, itinerary information and route information of the tested person, and integrates and analyzes this information with the virus detection results. Compared with the traditional decentralized data processing method, the present application scheme can realize real-time synchronization and comprehensive analysis of data in one system, thereby quickly identifying high-risk personnel and providing accurate warnings. The itinerary information acquisition module and the route acquisition module process complex geographic and behavioral data through intelligent algorithms, and analyze and evaluate the potential exposure risks of the tested person in real time. This comprehensive analysis capability based on big data and artificial intelligence is significantly superior to traditional manual tracking and simple data comparison methods. The analysis and early warning module can more comprehensively reflect the real risk level of the tested person from the comprehensive evaluation of multidimensional data based on the virus detection results, avoiding the early warning lag caused by incomplete data or untimely processing. The high sensitivity and multi-dimensional analysis capabilities of the system ensure the accuracy and timeliness of the early warning, which helps public health management departments to respond quickly and effectively to potential epidemic threats and minimize the risk of disease transmission. Through automated data collection, analysis and early warning, this application scheme greatly reduces the need for manual intervention, reduces operational complexity and error rate. Compared with traditional methods, the system can significantly improve the efficiency of public health prevention and control, and help relevant departments make faster and more accurate decisions in epidemic prevention and control. In addition, the system design also takes into account scalability and adaptability, and can be adjusted and optimized according to different application scenarios and virus types to meet different prevention and control needs. This application integrates high-sensitivity time-decomposition fluorescence immunoassay technology, multi-dimensional data collection and intelligent analysis methods to achieve efficient detection and accurate early warning of new coronavirus, monkeypox virus and influenza A virus. It not only improves the accuracy and efficiency of detection and risk assessment, but also provides a more comprehensive and intelligent solution for epidemic prevention and control, which has important application value in the field of public health.
[0026] In a second aspect, the present application proposes a control method for the high-sensitivity time-degradation fluorescence immunoassay early warning system described in the first aspect. Figure 2 A schematic flow chart of a control method for a high-sensitivity time-degrading fluorescent immunoassay early warning system provided in an embodiment of the present application includes: S210, controlling the above-mentioned measured person identity acquisition module to acquire the identity information of the measured person; S220, controlling the virus detection result acquisition module of the tested person to acquire the virus detection result of the tested person, wherein the virus detection result is determined based on the image information of the triple test reagent card, and the triple test reagent card is used to detect novel coronavirus, monkeypox virus and influenza A virus antigens; S230, controlling the measured person's travel information acquisition module to acquire the travel information of the measured person's corresponding means of transportation based on the person's identity information; S240, controlling the measured person's action route acquisition module to acquire the measured person's action route information in the waiting place corresponding to the transportation means after the measured person takes the transportation means based on the person's identity information; S250, controlling the above-mentioned analysis and warning module to generate warning information according to the above-mentioned virus detection results, travel information and the above-mentioned action route information.
[0027] Exemplarily, the identity information of the person under test is obtained by controlling the identity acquisition module of the person under test. The system first starts the identity acquisition module of the person under test to obtain and record the identity information of the person under test. This identity information may include an ID card number, a passport number, or other identity data that can uniquely identify the person under test. The obtained identity information will be used in subsequent steps to associate the virus test results, travel information, and route information of the person under test to ensure the accuracy and consistency of the data in the entire process.
[0028] The virus test results of the tested person are obtained by controlling the virus test result acquisition module of the tested person. The system controls the virus test result acquisition module of the tested person to perform virus test on the tested person. The virus test result is determined based on the image information of the triple test reagent card. The triple test reagent card is designed to detect novel coronavirus, monkeypox virus and influenza A virus antigens. The detection process reads the fluorescent signal on the triple test reagent card by time-delayed fluorescence immunoassay and converts the signal into a specific virus test result. The obtained virus test results will be used for subsequent risk assessment and generation of early warning information.
[0029] By controlling the test person's travel information acquisition module, the travel information of the corresponding means of transportation is obtained according to the test person's identity information. The test person's travel information acquisition module is controlled to find and extract the travel data associated with the person based on the identity information obtained in the previous step. These data may include detailed information such as the type of transportation (such as airplanes, trains, etc.) taken by the test person, the departure place, the destination, the departure time, and the arrival time. The travel information provides important background data for subsequent action route tracking and risk assessment.
[0030] By controlling the test person's route acquisition module, the test person's route information in the corresponding waiting place after boarding the transportation is obtained according to the test person's identity information. The test person's route acquisition module is controlled to record and track the test person's route in the waiting place by using identity information and positioning systems, cameras and other means. The route information includes the test person's stop location, stay time, passed areas and contact with other people in the waiting place. The obtained route information will be combined with the virus test results and itinerary information for further comprehensive analysis.
[0031] The control analysis and early warning module generates early warning information based on the virus test results, travel information, and route information of the tested person. The control analysis and early warning module conducts a comprehensive analysis of the virus test results, travel information, and route information obtained in the previous steps. The analysis and early warning module uses a specific algorithm to calculate the comprehensive risk score of the tested person and compares this score with the preset threshold. If the risk score exceeds the preset threshold, the system will generate an early warning message. This early warning message may indicate that the tested person has a high risk of infection and recommends further prevention and control measures, such as isolation, further testing, etc.
[0032] This application implements a complete and efficient early warning system, starting from obtaining the identity information of the tested person to generating early warning information through comprehensive analysis of virus test results, travel information, and action route information. Each step strictly controls the operation of the corresponding module to ensure the accuracy of the data and the timeliness of the early warning information, providing strong technical support for public health prevention and control.
[0033] In some examples, the triple test reagent card includes a test strip, a diluent, and a card housing; The test strip comprises a strip-shaped PVC bottom plate, on which a sample pad, a marker binding pad, a nitrocellulose membrane and absorbent paper are arranged in sequence from the first end to the second end, the sample pad is superimposed on the marker binding pad, and the nitrocellulose membrane is equidistantly arranged with a T1 reaction zone, a T2 reaction zone, a T3 reaction zone and a C reference zone from the first end to the second end; The T1 reaction area is coated with the novel coronavirus N protein mAb, the T2 reaction area is coated with the monkeypox virus A29L protein mAb, the T3 reaction area is coated with the influenza A virus NP protein mAb, and the C reference area is coated with goat anti-chicken IgY; The marker binding pad is sprayed with a mixture of novel coronavirus N protein mAb, monkeypox virus A29L protein mAb, influenza A virus NP protein mAb and chicken IgY labeled with lanthanide europium fluorescent microspheres; The card housing is composed of an upper housing and a lower housing. The upper housing is provided with a sample loading hole and a window hole which penetrate longitudinally. The sample loading hole is located directly above the sample pad. The window hole is located directly above the nitrocellulose membrane. On one side of the window hole, there are corresponding regional markings of the T1 reaction area, the T2 reaction area, the T3 reaction area and the C reference area. The test strip is placed on the lower card housing, and the upper housing is tightly buckled with the lower housing.
[0034] Exemplarily, the present invention provides a non-new coronavirus, monkeypox virus, influenza A virus antigen triple test reagent card, such as Figure 3 and Figure 4 As shown, it includes a test strip, a diluent and a card shell. The test strip includes a strip-shaped PVC bottom plate, on which a sample pad, a marker binding pad, a nitrocellulose membrane and a water-absorbing paper are arranged in sequence from left to right, wherein the sample pad is superimposed on the marker binding pad; the nitrocellulose membrane is evenly spaced from left to right, wherein the T1 reaction area is coated with a novel coronavirus N protein mAb, the T2 reaction area is coated with a monkeypox virus A29L protein mAb, the T3 reaction area is coated with an influenza A virus NP protein mAb, and the C reference area is coated with goat anti-chicken IgY; the marker binding pad is sprayed with a novel coronavirus N protein mAb labeled with lanthanide europium fluorescent microspheres, A mixture of monkeypox virus A29L protein mAb, influenza A virus NP protein mAb and chicken IgY; the card housing is composed of an upper and lower housing, the upper housing is provided with a longitudinally penetrating sample loading hole and a window hole, the sample loading hole is located directly above the sample pad, the window hole is located directly above the nitrocellulose membrane, and the left side of the window hole corresponds to the T1, T2, T3 and C reaction areas engraved with "T1", "T2", "T3", "C" logo; the test strip is placed on the lower card housing, and the upper housing is tightly buckled with the lower housing to form a new coronavirus, monkeypox virus, and influenza A virus triple test reagent card. The new coronavirus, monkeypox virus, and influenza A virus triple test reagent card and diluent constitute a new coronavirus, monkeypox virus, and influenza A virus triple test kit.
[0035] In some examples, the specific preparation and testing steps of the triple test reagent card include: Use lanthanide europium fluorescent microspheres to label the monoclonal antibodies of the SARS-CoV-2 N protein, monkeypox virus A29L protein, influenza A virus NP protein, and chicken IgY to make fluorescent detection probes; The fluorescent detection probes are diluted respectively, sprayed on the corresponding positions of the nitrocellulose membrane, and dried for storage; Soak the sample pad in the treatment solution and dry it, and cut the absorbent paper into preset sizes for later use; The marker binding pad, sample pad, nitrocellulose membrane and absorbent paper assembly are pasted on a PVC plate, cut into reagent strips and loaded into a card housing to prepare the above triple test reagent card.
[0036] Specifically, (I) Preparation of a triple test kit for novel coronavirus, monkeypox virus and influenza A virus antigens, including: 1. Preparation of fluorescent detection probes Lanthanide europium fluorescent microspheres were used as tracers to label the monoclonal antibody (mAb) of the N protein of the new coronavirus, the mAb of the A29L protein of the monkeypox virus, the mAb of the NP protein of the influenza A virus, and the chicken IgY to prepare fluorescent detection probes for the immune response system. The preparation method of the fluorescent detection probe is as follows: 1.1 Add 100 nm diameter lanthanide europium fluorescent microspheres into pure water, disperse by ultrasonication and centrifuge, take the precipitate and re-dissolve it in MES buffer to a microsphere concentration of 1 mg / mL; the concentration of MES used is 0.05 mol / L and the pH is 6.0.
[0037] 1.2 Take 1.5 mL of the reconstituted microspheres prepared in 1.1, add 2 mg each of 3-ethylcarbodiimide (EDC) and N-hydroxysuccinimide (NHS) in turn, shake and mix, react at room temperature for 3 h, centrifuge, take the precipitate and disperse it in 1.5 mL of PBS buffer; the PBS buffer is a phosphate buffer with a concentration of 0.05 mol / L and a pH of 7.6.
[0038] 1.3 Divide the reconstituted microspheres in 1.2 into 4 portions, 500 μL each. Add 0.1 mg of the novel coronavirus N protein mAb to one portion, 0.1 mg of the monkeypox virus A29L protein mAb to one portion, 0.1 mg of the influenza A virus NP protein mAb to one portion, and 0.1 mg of the chicken IgY to the other portion. Mix and react for 5 h at room temperature in the dark, then centrifuge and take the precipitate and resuspend and mix with 2 mL of the reconstitution solution; the reconstitution solution is prepared by adding 0.5% BSA (M / V) and 0.5% Tween-20 (M / V) to PBS (0.05 M, PH7.6).
[0039] 1.4 Preparation of marker conjugate pad Mix the four labeled fluorescent detection probes prepared in 1.3 to prepare a fluorescent probe mixture of the reagent; spray the mixture on the glass fiber membrane to prepare a marker binding pad, dry it in a 45℃ oven for 4 h, cool it to room temperature after drying, and put it in an aluminum foil bag to prevent moisture for later use.
[0040] 2. Dilute the novel coronavirus N protein mAb, monkeypox virus A29L protein mAb, influenza A virus NP protein mAb to 2.0 mg / mL and goat anti-chicken IgY to 1.5 mg / mL with PBS (0.05 M, PH7.2), respectively, and use a dot film gold sprayer to spray them on the T1 line, T2 line, T3 line and C line of the nitrocellulose membrane in sequence, dry them in a 45°C oven for 4 hours, cool them to room temperature after drying, and put them in an aluminum foil bag to prevent moisture for later use.
[0041] 3. Cut the glass cellulose membrane into 18 mm*30 cm strips, soak it in sample pad treatment solution, put it in an oven, dry it at 42℃ for 8 h, and prepare the sample pad. The sample pad treatment solution is prepared by adding 0.5% casein (M / V) and 0.5% Tween-20 (M / V) to PBS (0.1 M, PH8.2) solution.
[0042] 4. Cut the absorbent paper into strips of 20 mm*30 cm.
[0043] 5. Use a PVC board to paste the marker conjugate pad, sample pad, nitrocellulose membrane, and absorbent paper prepared above into a large board (such as Figure 4 ), cut into 5 mm wide reagent strips, and put them into the card shell to make a test card (such as Figure 3 ).
[0044] (II) Preparation of working dilution Add 50 mL of pure water, 0.101 g Na2HPO4, 0.057 g KH2PO4, 0.56 g NaCl, and 0.014 g KCL to a beaker, adjust the pH to 7.4, and make up to 70 mL.
[0045] (III) Preparation of standard curve for triple test reagent card The calibrated concentrations of the new coronavirus N protein, monkeypox virus A29L protein and influenza A virus NP protein were diluted in multiples and added to the joint test reagent cards respectively. After detection by fluorescent immunoassay analyzer, the "Reagent Card Standard Curve" software was used to automatically generate the new coronavirus, monkeypox virus and influenza A virus antigen detection standard curves according to the T1 / C, T2 / C, and T3 / C values corresponding to different concentrations. After verification by the quality control disk, the "Working Standard Curve" for detecting the three virus antigens was determined.
[0046] (IV) Principle and judgment of triple test reagent card When the test sample contains the novel coronavirus N protein, monkeypox virus A29L protein or influenza A virus NP protein, the related proteins in the sample will combine with the corresponding mAb labeled with the fluorescent microspheres to form an immune complex during the chromatography process, and combine with the corresponding antibody when flowing through the T line to form a double antibody sandwich immune reaction conjugate. The fluorescent immunoassay analyzer can detect the fluorescence signal of the lanthanide europium ion at the corresponding T line, and the intensity of the fluorescence signal is proportional to the concentration of the corresponding protein in the sample; conversely, if the corresponding protein does not exist in the tested sample, no fluorescence signal can be detected at the corresponding T line.
[0047] At the same time, the goat anti-chicken IgY in the C-line area will capture the labeled chicken IgY flowing through. Therefore, regardless of whether there are relevant viral antigens in the sample, the fluorescent immunoassay analyzer will detect the fluorescence signal of the lanthanide europium ion at the C-line; when the fluorescence signal at the C-line is less than 2 times the background fluorescence signal, the device will display that the test is invalid. The rules for judging the test results of the new coronavirus, monkeypox virus, and influenza A virus antigen triple test reagent card are detailed in Table 1, where "+" indicates a positive test result and "-" indicates a negative test result; Table 1 ; In some examples, the above-mentioned control of the above-mentioned test person virus detection result acquisition module to obtain the virus detection result of the test person includes: Based on the above-mentioned test person virus detection result acquisition module, the image information of the triple test reagent card of the above-mentioned test person is obtained; Obtaining a grayscale histogram of the image information of the triple test reagent card; Determine the image entropy value based on the grayscale histogram; When the image entropy value is greater than a preset threshold, the image information of the triple test reagent card is input into a first identifier to obtain a first virus detection result, wherein the first identifier is established based on a support vector machine; When the image entropy value is greater than or equal to the preset threshold, the image information of the triple test reagent card is input into a second identifier to obtain a second virus detection result, wherein the second identifier is established based on a deep residual network and a random forest algorithm; The first virus detection result or the second virus detection result is used as the virus detection result of the tested person.
[0048] For example, the triple test reagent card is a test tool for detecting novel coronavirus, monkeypox virus and influenza A virus antigens. Image information can be obtained through a camera or scanning device to ensure that the fluorescent signal on the triple test reagent card is captured for subsequent analysis and processing.
[0049] The system preprocesses the image of the triple test reagent card and converts it into a grayscale image. This conversion simplifies the color information into grayscale values of different intensities. Then, the system calculates the grayscale histogram to represent the distribution of pixels at different grayscale levels in the image. The grayscale histogram provides basic data for the subsequent image entropy value calculation.
[0050] Image entropy is an indicator of the amount of information in an image, indicating the complexity of the information in the image. The system calculates the entropy of the image by analyzing the grayscale histogram. A higher entropy value usually means that the image has more details and complexity, while a lower entropy value means that the image is simpler or uniform.
[0051] If the calculated image entropy value is greater than the preset threshold, the system inputs the image information of the triple test reagent card into the first identifier to obtain the first virus detection result. The system compares the image entropy value with the preset threshold. If the image entropy value is greater than the threshold, it means that the image information is high and is suitable for analysis using the first identifier based on the support vector machine (SVM). The first identifier processes the image information and generates the first virus detection result, which reflects the possible presence of viral antigens on the triple test reagent card.
[0052] If the image entropy value is greater than or equal to the preset threshold, the system inputs the image information of the triple test reagent card into the second identifier to obtain the second virus detection result. When the image entropy value is greater than or equal to the preset threshold, the system uses the second identifier based on the deep residual network (ResNet) and random forest algorithm for further analysis. Compared with the first identifier, the second identifier can process more complex and detailed image information, and generate the second virus detection result by combining the advantages of deep learning and ensemble learning.
[0053] The first virus detection result or the second virus detection result finally obtained is used as the virus detection result of the tested person.
[0054] The method proposed in the embodiment of the present application ensures the accuracy and reliability of the virus detection results. The system uses a triple test reagent card combined with a time-decomposition fluorescent immunoassay to obtain image information, calculate grayscale histograms, determine image entropy values, and select suitable identifiers (support vector machines or deep residual networks combined with random forests) according to different entropy values. The system uses image entropy values to determine the complexity of image information and dynamically selects appropriate identifiers for virus detection. In this way, regardless of the image quality, the system can make the best detection decision to ensure the reliability of the test results.
[0055] In some examples, the module for controlling the movement route acquisition of the measured person acquires the movement route information of the measured person in the waiting place corresponding to the transportation tool after the measured person takes the transportation tool based on the identity information of the measured person, including: Control the above-mentioned measured person's action route acquisition module to acquire entrance image information at the entrance of the waiting place; Matching the above-mentioned entrance image information with the identity information of the person being tested based on the first timestamp information to obtain entrance matching information; Control the above-mentioned measured person's action route acquisition module to acquire exit image information at the exit of the waiting place; Matching the exit image information with the identity information of the person being tested based on the second timestamp information to obtain exit matching information; Obtaining camera image information at different positions between the first timestamp information and the second timestamp information; According to all the camera graphic information, the above-mentioned entrance matching information and the above-mentioned exit matching information, matching is performed based on the FasterR-CNN algorithm and the Hungarian algorithm to obtain the action route information in the waiting area.
[0056] Exemplarily, by controlling the measured person's action route acquisition module, the entrance image information of the measured person at the entrance of the waiting place is obtained. When the measured person enters the waiting place, the system obtains the image information of the person at the entrance through a camera or other image acquisition device. The entrance image information contains the appearance features of the measured person and the time information (first timestamp information) of entering the waiting place, which lays the foundation for subsequent identity matching and action route tracking.
[0057] The obtained entrance image information is matched with the identity information of the person being tested, and the matching process is based on the first timestamp information. The system uses the first timestamp information in the entrance image information to associate and match it with the identity information of the person being tested. By comparing the facial features or other biometric features in the image, it is confirmed that the identity of the person in the image matches the previously obtained identity information, and the entrance matching information is obtained. This step ensures the accuracy of the entrance image information and provides effective identity confirmation for subsequent route tracking.
[0058] When the person under test leaves the waiting area, the system uses a camera or other image acquisition device to obtain the image information of the person at the exit. The exit image information records the appearance characteristics and departure time (second timestamp information) of the person under test, which will be used to associate with the entrance image information to help determine the person's complete route of action.
[0059] The acquired exit image information is matched with the identity information of the person being tested, and the matching process is based on the second timestamp information. The system uses the second timestamp information in the exit image information to associate and match it with the identity information of the person being tested. By analyzing the biometric features in the exit image and comparing it with the entrance matching information and identity information, the system confirms the identity of the person leaving the waiting area and obtains the exit matching information. This step ensures the identity of the person being tested is confirmed when leaving, which helps to fully record his or her route of action.
[0060] The system obtains camera image information of the person under test at different locations between the first timestamp and the second timestamp. Between the person under test entering and leaving the waiting area, the system uses multiple cameras to capture image information of the person under test at different locations. These image information records the route, stopover locations, and people the person under test came into contact with in the waiting area. These camera image information will serve as the basic data for subsequent route matching and analysis to help determine the specific movement trajectory of the person under test.
[0061] Based on all camera graphics information, entrance matching information and exit matching information, the Faster R-CNN algorithm and the Hungarian algorithm are used for matching to obtain the route information of the person under test in the waiting place. The Faster R-CNN algorithm is used to process the camera image information to identify and track the path of the person under test under different cameras. The Faster R-CNN algorithm determines whether the person in the image is the person under test by analyzing the object features in the image, and generates a preliminary route of action. Next, the system uses the Hungarian algorithm to optimize the matching of the entrance matching information, exit matching information and tracking data in the camera image information. The Hungarian algorithm ensures that the image information at each moment and under each camera is accurately associated with the route of action of the person under test by solving the optimal matching problem. Finally, the system obtains the complete route information of the person under test in the waiting place based on the matching results of the above algorithms. The route information will include detailed information such as the specific walking path, the place of stay and the people contacted by the person under test in the waiting place.
[0062] The method proposed in the embodiment of this application describes in detail how to use the identity information of the person being tested, the image information of the entrance and exit, and the image information of cameras at different locations, combined with the Faster R-CNN algorithm and the Hungarian algorithm, to accurately obtain the action route information of the person being tested in the waiting area. The system ensures the accuracy and completeness of the action route information through precise image processing and algorithm matching, providing a reliable data basis for subsequent risk assessment and early warning.
[0063] In some examples, the control of the analysis and warning module generates warning information according to the virus detection result, the travel information, and the action route information, including: The control analysis and early warning module determines the risk score R based on the following formula: ; α, β, and γ are weight coefficients used to adjust the influence of various factors on the final risk score R. V represents the risk score of the virus test result, T represents the risk score of the itinerary information, and M represents the risk score of the action route information. The above-mentioned warning information is determined based on the above-mentioned risk score R and threshold information.
[0064] Exemplarily, the system first obtains the risk score V of the virus detection result, the risk score T of the travel information, and the risk score M of the action route information by analyzing the early warning module.
[0065] Next, the system substitutes these scores into the above formula and uses the pre-set weight coefficients α, β, and γ to calculate the comprehensive risk score R. The comprehensive score R reflects the overall risk level of the person being tested, taking into account their virus infection status, travel history, and activities in the target area.
[0066] The calculated comprehensive risk score R is compared with the preset thresholds. These thresholds represent different risk levels and can be adjusted according to specific application scenarios. For example, multiple thresholds can be set to divide different levels such as high risk, medium risk and low risk.
[0067] The risk score V of the virus test results, the risk score T of the travel information, and the risk score M of the action route information are combined and weighted using the weight coefficients α, β, and γ to finally obtain the comprehensive risk score R. The system then compares the score with the preset threshold to determine whether to generate an early warning message and its level. This process ensures the accuracy and timeliness of the early warning information, helps to quickly identify potential high-risk individuals, and take corresponding prevention and control measures.
[0068] In some examples, the risk score V of the above virus detection result is determined based on the following formula: ; N represents the number of virus types detected; N max is the maximum reference value of the number of virus species; R 0is the basic reproduction number, which means the average number of people that an infected person can infect in the absence of intervention measures and a generally susceptible population; S is the coefficient of the impact of seasonal factors on virus transmission, reflecting the activity and transmission ability of the virus in different seasons; A is the coefficient of the virus transmission risk in the target area; P is the coefficient of the impact of population density in the area where the tested person is located on virus transmission; E is the coefficient of the intensity of epidemic prevention measures taken in the area or place; H is the coefficient of the health status of the tested person himself.
[0069] Exemplarily, N represents the number of virus types detected. N represents the number of virus types detected in the sample of the tested person. As the number of virus types detected increases, the risk of infection will also increase accordingly.
[0070] N max is the maximum reference value for the number of virus species. max It is the maximum number of virus types reference value set by the system, which is used to standardize the number of detected viruses for calculation in risk scoring. This value usually represents the maximum number of virus types that the detection system can identify.
[0071] R 0 The basic reproduction number R represents the average number of people that an infected person can infect in the absence of intervention measures and a generally susceptible population. 0 It is a key indicator for assessing the ability of a virus to spread. 0 The larger the value, the more contagious the virus is, resulting in an increase in the risk score V.
[0072] S is the coefficient of the seasonal factor on virus transmission, reflecting the activity and transmission ability of the virus in different seasons. The seasonal factor S reflects the impact of different seasons on virus transmission. For example, in the high-incidence season of influenza (such as winter), the S value may be higher, thereby increasing the risk assessment V.
[0073] A is the coefficient of the virus transmission risk in the target area. The virus transmission risk coefficient A in the target area assesses the possibility of virus transmission in a specific geographical area. The A value is higher in high-risk areas, such as areas with high incidence of epidemics, which will also increase the risk score V.
[0074] P is the coefficient of the population density of the area where the tested person is located on the spread of the virus. The population density coefficient P reflects the impact of the population density of the area where the tested person is located on the spread of the virus. The higher the population density, the greater the risk of virus transmission, resulting in an increase in the risk score V.
[0075] E is the coefficient of the intensity of the epidemic prevention measures taken in the area or place. The intensity coefficient of epidemic prevention measures E is used to evaluate the effectiveness of the epidemic prevention measures taken in the area or place. Strict epidemic prevention measures will reduce the E value and thus reduce the risk score V.
[0076] H is the coefficient of the health status of the person being tested. The health status coefficient H evaluates the health status of the person being tested, such as age, immunity, underlying diseases, etc. Individuals with poor health have higher H values, resulting in an increase in the risk score V.
[0077] The system first obtains the virus detection data of the tested person through the analysis and early warning module, including the number of detected virus types N. Then, the system combines the basic reproduction number R 0 , seasonal factor S, virus transmission risk coefficient A in the target area, population density coefficient P, epidemic prevention measures intensity coefficient E and health status coefficient H and other parameters are substituted into the above formula for calculation, and finally the risk score V of the virus detection result is obtained.
[0078] Through the above calculation formula, the system can comprehensively evaluate the infection risk of the tested person. The comprehensive consideration of factors such as the number of virus types, transmission ability, regional characteristics, population density, epidemic prevention measures and health status makes the risk score V more comprehensive and accurate. The final calculated V value will be used to calculate the comprehensive risk score R, and help the system generate corresponding early warning information, providing a scientific basis for public health decision-making.
[0079] In some examples, the specific steps for determining the risk score of the above travel information include: Get historical travel information for a preset period; Extracting risk area arrival information, travel frequency information and transportation type information based on the above historical travel information; A weighted sum is performed based on the risk area arrival information, the travel frequency information and the transportation type information to obtain a risk score for the trip information.
[0080] Exemplarily, first, the system obtains the historical travel information of the person under test within a preset period. The system extracts the travel records of the person under test within a preset period from relevant data sources (such as traffic records, mobile phone location data or other travel tracking systems) based on the consent of the relevant persons. The preset period can be the past 14 days, one month or other set time range, depending on the application scenario and risk assessment requirements. The historical travel information obtained includes detailed data such as the geographical locations visited by the person under test, the means of transportation taken, and the departure and arrival times.
[0081] The system analyzes the travel records of the tested person to identify whether he or she has ever been to a high-risk area (such as an outbreak area). The risk area arrival information includes the number of visits to the high-risk area, the length of stay, and the correlation with the severity of the epidemic in the area.
[0082] The system analyzes the travel frequency of the tested person within a preset period, including the number of trips and the frequency of travel (such as once a day, once every few days, etc.). Frequent travel may mean a higher risk of exposure, so travel frequency information is an important risk assessment indicator.
[0083] The system identifies the type of transportation used by the person being tested during the trip, such as airplane, train, bus, taxi, etc. Different types of transportation have different risks for virus transmission. For example, public transportation in a closed environment is usually accompanied by a higher risk of transmission.
[0084] The system calculates the risk score of the trip information by taking a weighted sum of the extracted risk area arrival information, travel frequency information, and transportation type information.
[0085] The system assigns certain weights to risk zone arrival information, travel frequency information, and transportation type information based on pre-set weights. These weights reflect the relative importance of each feature in the overall risk assessment.
[0086] The weight setting can be adjusted based on historical data, expert experience or specific application scenarios.
[0087] The system multiplies the feature scores of each piece of information by the corresponding weight and sums them up to derive the risk score of the trip information.
[0088] The calculation formula is as follows: T = w1 × risk area arrival information + w2 × travel frequency information + w3 × transportation type information Among them, w1, w2 and w3 represent the weights of the corresponding information respectively.
[0089] The final trip information risk score T represents the trip risk of the person under test within the preset period. The higher the score, the greater the possibility that the person is exposed to a high-risk environment during the trip, and thus has a higher weight in the overall risk assessment. Through a series of specific steps, the trip information risk score T of the person under test is accurately assessed. The system first obtains the historical trip information of the preset period, then extracts the key features (risk area arrival information, travel frequency information, and transportation type information), and finally calculates the comprehensive trip information risk score through weighted summation. This score provides important data support for the subsequent comprehensive risk assessment and early warning information generation, ensuring the scientificity and accuracy of the trip risk assessment.
[0090] In some examples, the specific steps of determining the risk score of the above-mentioned action route information include: Based on the action route information in the above waiting place, the time series analysis method is used to obtain the scores of the length of stay of the measured persons in different places; Based on the action route information in the above waiting place, the contact number score of the tested person is obtained by the Faster R-CNN method; Based on the action route information in the above waiting place, geospatial analysis is used in combination with the DBSCAN method to obtain the high-risk area score of the tested person; The risk score of the above-mentioned action route information is determined based on the length of stay scores at the above-mentioned different locations, the above-mentioned number of contacts scores and the above-mentioned high-risk area scores.
[0091] Exemplarily, the system uses time series analysis to obtain the length of stay scores of the tested persons at different locations based on the route information of the tested persons in the waiting place. The system records the length of stay of the tested persons at different locations by analyzing the route information of the tested persons in the waiting place. Using the time series analysis method, the system can identify the time series of the tested persons' stay at each specific location and evaluate the length of stay by analyzing these time series. The system converts the stay time at each location into a score, and the longer the stay time, the higher the score. This is because the longer the stay in a high-risk location, the higher the risk of exposure.
[0092] Next, the system uses the Faster R-CNN method to obtain the number of contacts of the tested person based on the route information of the tested person in the waiting area. Through camera monitoring and the Faster R-CNN algorithm, the contact between the tested person and other people in the waiting area is analyzed. The Faster R-CNN method is an advanced target detection algorithm that can identify and track people in the image in real time and determine the number of contacts around the tested person. Based on the number of contacts detected, the system calculates the score. The more people the contacts, the higher the score, reflecting that the risk of infection of the tested person increases with the increase in the number of contacts.
[0093] Then, based on the measured person's route information in the waiting area, the system uses geospatial analysis and combines the DBSCAN method to obtain the measured person's high-risk area score. The system first uses the geospatial analysis method to analyze the geographic location data in the waiting area to identify which areas belong to the high-risk area. Subsequently, the system uses the DBSCAN method (Density-Based Spatial Clustering of Applications with Noise) to perform cluster analysis on the measured person's route of action. The DBSCAN method is a clustering algorithm that can identify whether the measured person has stayed or passed through a high-risk area. The system calculates the high-risk area score based on the measured person's activities in the high-risk area. The high-risk area score depends on the frequency and time that the measured person stays in these areas. The longer the stay time or the higher the frequency, the higher the score.
[0094] Finally, the system uses a weighted summation method to combine the length of stay scores, number of contacts scores, and high-risk area scores at different locations to determine the final risk score for the action route information.
[0095] The method proposed in the embodiment of the present application accurately evaluates the risk score M of the action route information of the tested person in the waiting place. The system first obtains the residence time score based on the time series analysis method, then obtains the contact number score through the Faster R-CNN method, and finally uses geospatial analysis combined with the DBSCAN method to obtain the high-risk area score. By weighted summing these scores, the system finally calculates the risk score of the action route information, providing a reliable basis for subsequent risk assessment and warning generation. This process ensures the comprehensiveness and scientificity of the risk assessment of the action route information.
[0096] The present application is described with reference to the flowcharts and / or block diagrams of the methods, devices (systems), and computer program products according to the embodiments of the present application. It should be understood that each process and / or block in the flowchart and / or block diagram, as well as the combination of the processes and / or blocks in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded computer, or other programmable data processing device to generate a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.
[0097] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.
[0098] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.
[0099] An embodiment of the present application further provides a computer program product, which includes computer software instructions. When the computer software instructions are executed on a processing device, the processing device executes the process of the control method in the corresponding embodiment.
[0100] The computer program product includes one or more computer instructions. When the computer program instructions are loaded and executed on the computer, the process or function according to the embodiment of the present application is generated in whole or in part. The computer may be a general-purpose computer, a special-purpose computer, a computer network, or other programmable device. The computer instructions may be stored in a computer-readable storage medium, or transmitted from one computer-readable storage medium to another computer-readable storage medium. For example, the computer instructions may be transmitted from one website site, computer, server or data center to another website site, computer, server or data center by wired (e.g., coaxial cable, optical fiber, digital subscriber line (DSL)) or wireless (e.g., infrared, wireless, microwave, etc.) means. The computer-readable storage medium may be any available medium that a computer can store or a data storage device such as a server or data center that includes one or more available media integrated. The available medium may be a magnetic medium (e.g., a floppy disk, a hard disk, a tape), an optical medium (e.g., a DVD), or a semiconductor medium (e.g., a solid state disk (SSD)), etc.
[0101] Those skilled in the art can clearly understand that, for the convenience and brevity of description, the specific working processes of the systems, devices and units described above can refer to the corresponding processes in the aforementioned method embodiments and will not be repeated here.
[0102] In the several embodiments provided in the present application, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic. For example, the division of units is only a logical function division. There may be other division methods in actual implementation. For example, multiple units or components can be combined or integrated into another system, or some features can be ignored or not executed. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be an indirect coupling or communication connection through some interfaces, devices or units, which can be electrical, mechanical or other forms.
[0103] The units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, that is, they may be located in one place or distributed on multiple network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of this embodiment.
[0104] In addition, each functional unit in each embodiment of the present application may be integrated into one processing unit, or each unit may exist physically separately, or two or more units may be integrated into one unit. The above-mentioned integrated unit may be implemented in the form of hardware or in the form of software functional units.
[0105] If the integrated unit is implemented in the form of a software functional unit and sold or used as an independent product, it can be stored in a computer-readable storage medium. Based on this understanding, the technical solution of the present application is essentially or the part that contributes to the prior art or all or part of the technical solution can be embodied in the form of a software product. The computer software product is stored in a storage medium, including a number of instructions to enable a computer device (which can be a personal computer, server, or network device, etc.) to execute all or part of the steps of the various embodiments of the present application. The aforementioned storage medium includes: U disk, mobile hard disk, read-only memory (ROM), random access memory (RAM), disk or optical disk and other media that can store program codes.
[0106] The above embodiments are only used to illustrate the technical solutions of the present application, rather than to limit them. Although the present application has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present application.
Claims
1. A high-sensitivity time-degrading fluorescent immunoassay early warning system, characterized in that: include: The module for obtaining the identity of the person under test is used to obtain the identity information of the person under test; A module for acquiring virus test results of a tested person, which is used to obtain the virus test results of the tested person, wherein the virus test results are determined based on the image information of a triple test reagent card, wherein the triple test reagent card is used to detect novel coronavirus, monkeypox virus and influenza A virus antigens, and wherein the triple test reagent card is used to determine the virus test results based on a time-dependent fluorescence immunoassay method; A module for acquiring the itinerary information of the person under test, used to acquire the itinerary information of the transportation vehicle taken by the person under test based on the identity information of the person; A module for acquiring the movement route of the person under test, for acquiring the movement route information of the person under test in the waiting place corresponding to the transportation means after the person under test takes the transportation means based on the identity information of the person under test; The analysis and warning module is used to generate warning information based on the virus detection results, travel information and the action route information.
2. A control method for the high-sensitivity time-degrading fluorescent immunoassay early warning system according to claim 1, characterized in that: include: Controlling the measured person identity acquisition module to acquire the measured person's identity information; Controlling the virus detection result acquisition module of the tested person to acquire the virus detection result of the tested person, wherein the virus detection result is determined based on the image information of the triple test reagent card, and the triple test reagent card is used to detect the novel coronavirus, monkeypox virus and influenza A virus antigen; Control the measured person's travel information acquisition module to acquire the travel information of the measured person's corresponding means of transportation based on the person's identity information; Control the measured person's action route acquisition module to acquire the measured person's action route information in the waiting place corresponding to the transportation tool after the measured person takes the transportation tool based on the person's identity information; The analysis and warning module is controlled to form warning information according to the virus detection result, the travel information and the action route information.
3. The control method according to claim 2, characterized in that: The triple test reagent card comprises a test strip, a diluent and a card housing; The test strip comprises a strip-shaped PVC bottom plate, on which a sample pad, a marker binding pad, a nitrocellulose membrane and absorbent paper are arranged in sequence from the first end to the second end, the sample pad is superimposed on the marker binding pad, and the nitrocellulose membrane is equidistantly arranged with a T1 reaction zone, a T2 reaction zone, a T3 reaction zone and a C reference zone from the first end to the second end; The T1 reaction area is coated with the novel coronavirus N protein mAb, the T2 reaction area is coated with the monkeypox virus A29L protein mAb, the T3 reaction area is coated with the influenza A virus NP protein mAb, and the C reference area is coated with goat anti-chicken IgY; The marker conjugate pad is sprayed with a mixture of novel coronavirus N protein mAb, monkeypox virus A29L protein mAb, influenza A virus NP protein mAb and chicken IgY labeled with lanthanide europium fluorescent microspheres; The card housing is composed of an upper housing and a lower housing, the upper housing is provided with a sample loading hole and a window hole running longitudinally, the sample loading hole is located directly above the sample pad, the window hole is located directly above the nitrocellulose membrane, and on one side of the window hole are corresponding regional markings of a T1 reaction area, a T2 reaction area, a T3 reaction area and a C reference area; The test strip is placed on the lower card housing, and the upper housing is tightly buckled with the lower housing.
4. The control method according to claim 3, characterized in that: The specific preparation and testing steps of the triple test reagent card include: Use lanthanide europium fluorescent microspheres to label the monoclonal antibodies of the SARS-CoV-2 N protein, monkeypox virus A29L protein, influenza A virus NP protein, and chicken IgY to make fluorescent detection probes; The fluorescent detection probes are diluted respectively, sprayed on the corresponding positions of the nitrocellulose membrane, and dried for storage; Soak the sample pad in the treatment solution and dry it, and cut the absorbent paper into preset sizes for later use; The marker binding pad, sample pad, nitrocellulose membrane and absorbent paper assembly are pasted on a PVC plate, cut into reagent strips and loaded into a card housing to prepare the triple test reagent card.
5. The control method according to claim 2, characterized in that: The controlling the module for obtaining the virus detection result of the tested person to obtain the virus detection result of the tested person includes: Acquire the image information of the triple test reagent card of the tested person based on the tested person virus test result acquisition module; Obtaining a grayscale histogram of the image information of the triple test reagent card; Determining an image entropy value based on the grayscale histogram; When the image entropy value is greater than a preset threshold, the image information of the triple test reagent card is input into a first identifier to obtain a first virus detection result, wherein the first identifier is established based on a support vector machine; When the image entropy value is greater than or equal to the preset threshold, the image information of the triple test reagent card is input into a second identifier to obtain a second virus detection result, wherein the second identifier is established based on a deep residual network and a random forest algorithm; The first virus detection result or the second virus detection result is used as the virus detection result of the tested person.
6. The control method according to claim 2, characterized in that: The module for controlling the movement route acquisition of the measured person acquires the movement route information of the measured person in the waiting place corresponding to the transportation tool after the measured person takes the transportation tool based on the identity information of the person, including: Control the measured person's action route acquisition module to acquire entrance image information at the entrance of the waiting place; Matching the entrance image information with the identity information of the person being tested based on the first timestamp information to obtain entrance matching information; Control the measured person's action route acquisition module to acquire exit image information at the exit of the waiting place; Matching the exit image information with the identity information of the person being tested based on the second timestamp information to obtain exit matching information; Acquire camera image information at different positions between the first timestamp information and the second timestamp information; According to all the camera graphic information, the entrance matching information and the exit matching information, matching is performed based on the Faster R-CNN algorithm and the Hungarian algorithm to obtain the action route information in the waiting area.
7. The control method according to claim 2, characterized in that: The controlling the analysis and warning module to form warning information according to the virus detection result, the travel information and the action route information includes: The analysis and early warning module is controlled to determine the risk score R based on the following formula: ; α, β, and γ are weight coefficients used to adjust the influence of various factors on the final risk score R. V represents the risk score of the virus test result, T represents the risk score of the itinerary information, and M represents the risk score of the action route information. The warning information is determined based on the risk score R and threshold information.
8. The control method according to claim 7, characterized in that: The risk score V of the virus detection result is determined based on the following formula: ; N represents the number of virus types detected; N max is the maximum reference value for the number of virus species; R0 is the basic reproduction number, which indicates the average number of people that an infected person can infect in the absence of intervention measures and a generally susceptible population; S is the coefficient of the impact of seasonal factors on virus transmission, reflecting the activity and transmission ability of the virus in different seasons; A is the coefficient of the virus transmission risk in the target area; P is the coefficient of the impact of population density in the area where the tested person is located on virus transmission; E is the coefficient of the intensity of epidemic prevention measures taken in the area or place; H is the coefficient of the health status of the tested person himself.
9. The control method according to claim 7, characterized in that: The specific steps of determining the risk score of the trip information include: Get historical travel information for a preset period; Extracting risk area arrival information, travel frequency information and transportation type information based on the historical travel information; A weighted sum is performed based on the risk zone arrival information, the travel frequency information, and the transportation tool type information to obtain a risk score for the trip information.
10. The control method according to claim 7, characterized in that: The specific steps of determining the risk score of the action route information include: Based on the action route information in the waiting place, the time series analysis method is used to obtain the stay time scores of the measured persons in different locations; Based on the action route information in the waiting place, a contact number score of the tested person is obtained by using the Faster R-CNN method; Based on the action route information in the waiting place, geospatial analysis is used in combination with the DBSCAN method to obtain the high-risk area score of the tested person; The risk score of the action route information is determined based on the residence time scores of the different locations, the contact number scores and the high-risk area scores.
Citation Information
Patent Citations
Novel coronavirus and influenza virus detection kit and detection method
CN111458499A
Time-resolved fluorescence immunochromatographic test strip for detecting influenza A virus, influenza B virus and novel coronavirus antigen and preparation method thereof
CN111948389A
Infectious disease condition prevention and control system and method
CN114121302A
Detection reagent for immunoassay test strip
CN115389760A
Method and kit for detecting monkey pox virus
CN117659170A
